These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 12973192)

  • 1. Pro/Con debate of activated protein C in severe sepsis.
    Joore JC; van Leeuwen HJ; Meulenbelt J; Tobé TJ; Fijen JW
    Crit Care Med; 2003 Aug; 31(8):2249. PubMed ID: 12973192
    [No Abstract]   [Full Text] [Related]  

  • 2. Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis.
    Yan SB; Dhainaut JF; Schwarz HP; Ehrlich HJ
    Crit Care Med; 2004 Feb; 32(2):618; author reply 618-9. PubMed ID: 14758203
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated protein C: cost-effective or costly?
    Brar SS; Manns BJ
    Crit Care; 2007; 11(5):164. PubMed ID: 17875223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Ott A
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2196-7. PubMed ID: 11727624
    [No Abstract]   [Full Text] [Related]  

  • 5. Activated protein C for the treatment of severe sepsis.
    Houston G; Cuthbertson BH
    Clin Microbiol Infect; 2009 Apr; 15(4):319-24. PubMed ID: 19416303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural anticoagulant inhibitors: activated Protein C.
    Aird WC
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):161-82. PubMed ID: 15171965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protein C concentrate in the treatment of severe sepsis in the pediatric setting].
    Ramos Guerrero R; López Castilla JD; Atienza Fernández M; Bautista Paloma J; Ramos Guerrero AJ; Muñoz Sáez M; Carranza Conde M; Soult Rubio JA
    Farm Hosp; 2003; 27(6):391-5. PubMed ID: 14974885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of activated protein C in real-life clinical practice.
    Dhainaut JF; Payet S; Vallet B; França LR; Annane D; Bollaert PE; Le Tulzo Y; Runge I; Malledant Y; Guidet B; Le Lay K; Launois R;
    Crit Care; 2007; 11(5):R99. PubMed ID: 17822547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Two cases of severe sepsis successfully treated with activated protein C].
    Aguirre Caballero A; Gutiérrez-Jodra Gamboa A; García Pérez Del Río JI; Lavilla Díaz M
    Rev Esp Anestesiol Reanim; 2003 Dec; 50(10):539-43. PubMed ID: 14737782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Medical-economic evaluation of severe sepsis].
    Guidet B
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():28-30. PubMed ID: 15359937
    [No Abstract]   [Full Text] [Related]  

  • 11. Adjunctive corticosteroid therapy in pediatric severe sepsis: many unsolved questions.
    Leclerc F; Botte A; Chêne G; Leteurtre S
    Pediatr Crit Care Med; 2011 Jan; 12(1):101-2. PubMed ID: 21209569
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of protein C concentrate in adult patients with severe sepsis and septic shock].
    Baratto F; Michielan F; Gagliardi G; Di Gregorio G; Pasqualetto A; Meroni M; Giron GP
    Minerva Anestesiol; 2004 May; 70(5):351-6. PubMed ID: 15181415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive corticosteroid therapy in pediatric severe sepsis: observations from the RESOLVE study.
    Zimmerman JJ; Williams MD
    Pediatr Crit Care Med; 2011 Jan; 12(1):2-8. PubMed ID: 20228689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Exogenous activated protein C in severe sepsis].
    Mamontova OA; Protsenko DN; Eliutin DV; Kirienko PN; Gel'fand BR
    Anesteziol Reanimatol; 2005; (3):42-5. PubMed ID: 16076046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting unmet needs in patients with sepsis: the role of drotrecogin alfa (activated).
    McEvoy M
    Am J Crit Care; 2003 Sep; 12(5):398; author reply 398. PubMed ID: 14503421
    [No Abstract]   [Full Text] [Related]  

  • 17. The promise of protein C.
    Griffin JH; Fernández JA; Mosnier LO; Liu D; Cheng T; Guo H; Zlokovic BV
    Blood Cells Mol Dis; 2006; 36(2):211-6. PubMed ID: 16464623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activated C protein in severe sepsis].
    Martynov AN; Gel'fand EB; Eliutin DV; Gel'fand BR
    Anesteziol Reanimatol; 2004; (4):50-1. PubMed ID: 15468558
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescription of rh-APC differs substantially among western European countries.
    Schultz MJ; Levi M
    Intensive Care Med; 2006 Apr; 32(4):630-1. PubMed ID: 16520998
    [No Abstract]   [Full Text] [Related]  

  • 20. After Xigris, researchers look to new targets to combat sepsis.
    Williams SC
    Nat Med; 2012 Jul; 18(7):1001. PubMed ID: 22772543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.